Exploration of docetaxel palmitate and its solid lipid nanoparticles as a novel option for alleviating the rising concern of multi-drug resistance
Display Omitted
Gespeichert in:
| Autor*in: |
Kaushik, Lokesh [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2020 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
Enthalten in: Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides - Nigolian, H. ELSEVIER, 2022, New York, NY [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:578 ; year:2020 ; day:30 ; month:03 ; pages:0 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.ijpharm.2020.119088 |
|---|
| Katalog-ID: |
ELV049623176 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV049623176 | ||
| 003 | DE-627 | ||
| 005 | 20230624154652.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200518s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ijpharm.2020.119088 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001009.pica |
| 035 | |a (DE-627)ELV049623176 | ||
| 035 | |a (ELSEVIER)S0378-5173(20)30072-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.61 |2 bkl | ||
| 100 | 1 | |a Kaushik, Lokesh |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Exploration of docetaxel palmitate and its solid lipid nanoparticles as a novel option for alleviating the rising concern of multi-drug resistance |
| 264 | 1 | |c 2020 | |
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Display Omitted | ||
| 650 | 7 | |a Drug conjugate |2 Elsevier | |
| 650 | 7 | |a SLNs |2 Elsevier | |
| 650 | 7 | |a Computational studies |2 Elsevier | |
| 650 | 7 | |a Pharmacokinetics |2 Elsevier | |
| 650 | 7 | |a Taxanes |2 Elsevier | |
| 650 | 7 | |a In-vivo tumor |2 Elsevier | |
| 700 | 1 | |a Srivastava, Shubham |4 oth | |
| 700 | 1 | |a Panjeta, Anshul |4 oth | |
| 700 | 1 | |a Chaudhari, Dasharath |4 oth | |
| 700 | 1 | |a Ghadi, Rohan |4 oth | |
| 700 | 1 | |a Kuche, Kaushik |4 oth | |
| 700 | 1 | |a Malik, Ruchi |4 oth | |
| 700 | 1 | |a Preet, Simran |4 oth | |
| 700 | 1 | |a Jain, Sanyog |4 oth | |
| 700 | 1 | |a Raza, Kaisar |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Nigolian, H. ELSEVIER |t Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |d 2022 |g New York, NY [u.a.] |w (DE-627)ELV008932840 |
| 773 | 1 | 8 | |g volume:578 |g year:2020 |g day:30 |g month:03 |g pages:0 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ijpharm.2020.119088 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 936 | b | k | |a 44.61 |j Innere Medizin |q VZ |
| 951 | |a AR | ||
| 952 | |d 578 |j 2020 |b 30 |c 0330 |h 0 | ||
| author_variant |
l k lk |
|---|---|
| matchkey_str |
kaushiklokeshsrivastavashubhampanjetaans:2020----:xlrtoodctxlamttadtsldiinnprilssnvlpinoalvaighr |
| hierarchy_sort_str |
2020 |
| bklnumber |
44.61 |
| publishDate |
2020 |
| allfields |
10.1016/j.ijpharm.2020.119088 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001009.pica (DE-627)ELV049623176 (ELSEVIER)S0378-5173(20)30072-7 DE-627 ger DE-627 rakwb eng 610 VZ 44.61 bkl Kaushik, Lokesh verfasserin aut Exploration of docetaxel palmitate and its solid lipid nanoparticles as a novel option for alleviating the rising concern of multi-drug resistance 2020 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Drug conjugate Elsevier SLNs Elsevier Computational studies Elsevier Pharmacokinetics Elsevier Taxanes Elsevier In-vivo tumor Elsevier Srivastava, Shubham oth Panjeta, Anshul oth Chaudhari, Dasharath oth Ghadi, Rohan oth Kuche, Kaushik oth Malik, Ruchi oth Preet, Simran oth Jain, Sanyog oth Raza, Kaisar oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:578 year:2020 day:30 month:03 pages:0 https://doi.org/10.1016/j.ijpharm.2020.119088 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 578 2020 30 0330 0 |
| spelling |
10.1016/j.ijpharm.2020.119088 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001009.pica (DE-627)ELV049623176 (ELSEVIER)S0378-5173(20)30072-7 DE-627 ger DE-627 rakwb eng 610 VZ 44.61 bkl Kaushik, Lokesh verfasserin aut Exploration of docetaxel palmitate and its solid lipid nanoparticles as a novel option for alleviating the rising concern of multi-drug resistance 2020 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Drug conjugate Elsevier SLNs Elsevier Computational studies Elsevier Pharmacokinetics Elsevier Taxanes Elsevier In-vivo tumor Elsevier Srivastava, Shubham oth Panjeta, Anshul oth Chaudhari, Dasharath oth Ghadi, Rohan oth Kuche, Kaushik oth Malik, Ruchi oth Preet, Simran oth Jain, Sanyog oth Raza, Kaisar oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:578 year:2020 day:30 month:03 pages:0 https://doi.org/10.1016/j.ijpharm.2020.119088 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 578 2020 30 0330 0 |
| allfields_unstemmed |
10.1016/j.ijpharm.2020.119088 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001009.pica (DE-627)ELV049623176 (ELSEVIER)S0378-5173(20)30072-7 DE-627 ger DE-627 rakwb eng 610 VZ 44.61 bkl Kaushik, Lokesh verfasserin aut Exploration of docetaxel palmitate and its solid lipid nanoparticles as a novel option for alleviating the rising concern of multi-drug resistance 2020 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Drug conjugate Elsevier SLNs Elsevier Computational studies Elsevier Pharmacokinetics Elsevier Taxanes Elsevier In-vivo tumor Elsevier Srivastava, Shubham oth Panjeta, Anshul oth Chaudhari, Dasharath oth Ghadi, Rohan oth Kuche, Kaushik oth Malik, Ruchi oth Preet, Simran oth Jain, Sanyog oth Raza, Kaisar oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:578 year:2020 day:30 month:03 pages:0 https://doi.org/10.1016/j.ijpharm.2020.119088 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 578 2020 30 0330 0 |
| allfieldsGer |
10.1016/j.ijpharm.2020.119088 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001009.pica (DE-627)ELV049623176 (ELSEVIER)S0378-5173(20)30072-7 DE-627 ger DE-627 rakwb eng 610 VZ 44.61 bkl Kaushik, Lokesh verfasserin aut Exploration of docetaxel palmitate and its solid lipid nanoparticles as a novel option for alleviating the rising concern of multi-drug resistance 2020 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Drug conjugate Elsevier SLNs Elsevier Computational studies Elsevier Pharmacokinetics Elsevier Taxanes Elsevier In-vivo tumor Elsevier Srivastava, Shubham oth Panjeta, Anshul oth Chaudhari, Dasharath oth Ghadi, Rohan oth Kuche, Kaushik oth Malik, Ruchi oth Preet, Simran oth Jain, Sanyog oth Raza, Kaisar oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:578 year:2020 day:30 month:03 pages:0 https://doi.org/10.1016/j.ijpharm.2020.119088 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 578 2020 30 0330 0 |
| allfieldsSound |
10.1016/j.ijpharm.2020.119088 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001009.pica (DE-627)ELV049623176 (ELSEVIER)S0378-5173(20)30072-7 DE-627 ger DE-627 rakwb eng 610 VZ 44.61 bkl Kaushik, Lokesh verfasserin aut Exploration of docetaxel palmitate and its solid lipid nanoparticles as a novel option for alleviating the rising concern of multi-drug resistance 2020 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Drug conjugate Elsevier SLNs Elsevier Computational studies Elsevier Pharmacokinetics Elsevier Taxanes Elsevier In-vivo tumor Elsevier Srivastava, Shubham oth Panjeta, Anshul oth Chaudhari, Dasharath oth Ghadi, Rohan oth Kuche, Kaushik oth Malik, Ruchi oth Preet, Simran oth Jain, Sanyog oth Raza, Kaisar oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:578 year:2020 day:30 month:03 pages:0 https://doi.org/10.1016/j.ijpharm.2020.119088 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 578 2020 30 0330 0 |
| language |
English |
| source |
Enthalten in Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides New York, NY [u.a.] volume:578 year:2020 day:30 month:03 pages:0 |
| sourceStr |
Enthalten in Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides New York, NY [u.a.] volume:578 year:2020 day:30 month:03 pages:0 |
| format_phy_str_mv |
Article |
| bklname |
Innere Medizin |
| institution |
findex.gbv.de |
| topic_facet |
Drug conjugate SLNs Computational studies Pharmacokinetics Taxanes In-vivo tumor |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
| authorswithroles_txt_mv |
Kaushik, Lokesh @@aut@@ Srivastava, Shubham @@oth@@ Panjeta, Anshul @@oth@@ Chaudhari, Dasharath @@oth@@ Ghadi, Rohan @@oth@@ Kuche, Kaushik @@oth@@ Malik, Ruchi @@oth@@ Preet, Simran @@oth@@ Jain, Sanyog @@oth@@ Raza, Kaisar @@oth@@ |
| publishDateDaySort_date |
2020-01-30T00:00:00Z |
| hierarchy_top_id |
ELV008932840 |
| dewey-sort |
3610 |
| id |
ELV049623176 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV049623176</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624154652.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">200518s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ijpharm.2020.119088</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001009.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV049623176</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0378-5173(20)30072-7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.61</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Kaushik, Lokesh</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Exploration of docetaxel palmitate and its solid lipid nanoparticles as a novel option for alleviating the rising concern of multi-drug resistance</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Display Omitted</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drug conjugate</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SLNs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Computational studies</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmacokinetics</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Taxanes</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">In-vivo tumor</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Srivastava, Shubham</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Panjeta, Anshul</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chaudhari, Dasharath</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ghadi, Rohan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kuche, Kaushik</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Malik, Ruchi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Preet, Simran</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jain, Sanyog</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Raza, Kaisar</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Nigolian, H. ELSEVIER</subfield><subfield code="t">Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides</subfield><subfield code="d">2022</subfield><subfield code="g">New York, NY [u.a.]</subfield><subfield code="w">(DE-627)ELV008932840</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:578</subfield><subfield code="g">year:2020</subfield><subfield code="g">day:30</subfield><subfield code="g">month:03</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ijpharm.2020.119088</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.61</subfield><subfield code="j">Innere Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">578</subfield><subfield code="j">2020</subfield><subfield code="b">30</subfield><subfield code="c">0330</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| author |
Kaushik, Lokesh |
| spellingShingle |
Kaushik, Lokesh ddc 610 bkl 44.61 Elsevier Drug conjugate Elsevier SLNs Elsevier Computational studies Elsevier Pharmacokinetics Elsevier Taxanes Elsevier In-vivo tumor Exploration of docetaxel palmitate and its solid lipid nanoparticles as a novel option for alleviating the rising concern of multi-drug resistance |
| authorStr |
Kaushik, Lokesh |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV008932840 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 VZ 44.61 bkl Exploration of docetaxel palmitate and its solid lipid nanoparticles as a novel option for alleviating the rising concern of multi-drug resistance Drug conjugate Elsevier SLNs Elsevier Computational studies Elsevier Pharmacokinetics Elsevier Taxanes Elsevier In-vivo tumor Elsevier |
| topic |
ddc 610 bkl 44.61 Elsevier Drug conjugate Elsevier SLNs Elsevier Computational studies Elsevier Pharmacokinetics Elsevier Taxanes Elsevier In-vivo tumor |
| topic_unstemmed |
ddc 610 bkl 44.61 Elsevier Drug conjugate Elsevier SLNs Elsevier Computational studies Elsevier Pharmacokinetics Elsevier Taxanes Elsevier In-vivo tumor |
| topic_browse |
ddc 610 bkl 44.61 Elsevier Drug conjugate Elsevier SLNs Elsevier Computational studies Elsevier Pharmacokinetics Elsevier Taxanes Elsevier In-vivo tumor |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
s s ss a p ap d c dc r g rg k k kk r m rm s p sp s j sj k r kr |
| hierarchy_parent_title |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
| hierarchy_parent_id |
ELV008932840 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV008932840 |
| title |
Exploration of docetaxel palmitate and its solid lipid nanoparticles as a novel option for alleviating the rising concern of multi-drug resistance |
| ctrlnum |
(DE-627)ELV049623176 (ELSEVIER)S0378-5173(20)30072-7 |
| title_full |
Exploration of docetaxel palmitate and its solid lipid nanoparticles as a novel option for alleviating the rising concern of multi-drug resistance |
| author_sort |
Kaushik, Lokesh |
| journal |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
| journalStr |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2020 |
| contenttype_str_mv |
zzz |
| container_start_page |
0 |
| author_browse |
Kaushik, Lokesh |
| container_volume |
578 |
| class |
610 VZ 44.61 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Kaushik, Lokesh |
| doi_str_mv |
10.1016/j.ijpharm.2020.119088 |
| dewey-full |
610 |
| title_sort |
exploration of docetaxel palmitate and its solid lipid nanoparticles as a novel option for alleviating the rising concern of multi-drug resistance |
| title_auth |
Exploration of docetaxel palmitate and its solid lipid nanoparticles as a novel option for alleviating the rising concern of multi-drug resistance |
| abstract |
Display Omitted |
| abstractGer |
Display Omitted |
| abstract_unstemmed |
Display Omitted |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| title_short |
Exploration of docetaxel palmitate and its solid lipid nanoparticles as a novel option for alleviating the rising concern of multi-drug resistance |
| url |
https://doi.org/10.1016/j.ijpharm.2020.119088 |
| remote_bool |
true |
| author2 |
Srivastava, Shubham Panjeta, Anshul Chaudhari, Dasharath Ghadi, Rohan Kuche, Kaushik Malik, Ruchi Preet, Simran Jain, Sanyog Raza, Kaisar |
| author2Str |
Srivastava, Shubham Panjeta, Anshul Chaudhari, Dasharath Ghadi, Rohan Kuche, Kaushik Malik, Ruchi Preet, Simran Jain, Sanyog Raza, Kaisar |
| ppnlink |
ELV008932840 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.ijpharm.2020.119088 |
| up_date |
2024-07-06T22:06:00.981Z |
| _version_ |
1803869026761310208 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV049623176</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624154652.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">200518s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ijpharm.2020.119088</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001009.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV049623176</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0378-5173(20)30072-7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.61</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Kaushik, Lokesh</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Exploration of docetaxel palmitate and its solid lipid nanoparticles as a novel option for alleviating the rising concern of multi-drug resistance</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Display Omitted</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drug conjugate</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SLNs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Computational studies</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmacokinetics</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Taxanes</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">In-vivo tumor</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Srivastava, Shubham</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Panjeta, Anshul</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chaudhari, Dasharath</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ghadi, Rohan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kuche, Kaushik</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Malik, Ruchi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Preet, Simran</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jain, Sanyog</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Raza, Kaisar</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Nigolian, H. ELSEVIER</subfield><subfield code="t">Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides</subfield><subfield code="d">2022</subfield><subfield code="g">New York, NY [u.a.]</subfield><subfield code="w">(DE-627)ELV008932840</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:578</subfield><subfield code="g">year:2020</subfield><subfield code="g">day:30</subfield><subfield code="g">month:03</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ijpharm.2020.119088</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.61</subfield><subfield code="j">Innere Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">578</subfield><subfield code="j">2020</subfield><subfield code="b">30</subfield><subfield code="c">0330</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| score |
7.4006004 |